(Q37670886)

21 August 2017

1 reference

title

Treatment of osteoarthritis in hypertensive patients (English)

1 reference

21 August 2017

0 references

1

1 reference

21 August 2017

Thomas M MacDonald

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Pharmacotherapy

21 August 2017

published in

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

393-403

1 reference

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Ag

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effect of ibuprofen on cardioprotective effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Non-narcotic analgesic dose and risk of incident hypertension in US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Analgesic use and risk of subsequent hypertension in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Relationship between COX-2 specific inhibitors and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

The clinical significance of inhibition of renal prostaglandin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Nonnarcotic analgesics and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Role of prostaglandins in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Nonsteroidal anti-inflammatory drugs and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Frequency of analgesic use and risk of hypertension in younger women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Sodium in soluble paracetamol may be linked to raised blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

A common pathway of nitric oxide release from AZD3582 and glyceryl trinitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903496422

10.1517/14656560903496422

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference